{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:34:46Z","timestamp":1790832886083,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences","award":["2019PT330003"],"award-info":[{"award-number":["2019PT330003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12020-021-02745-7","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T10:02:43Z","timestamp":1621850563000},"page":"682-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension"],"prefix":"10.1007","volume":"73","author":[{"given":"Meng-hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-8566","authenticated-orcid":false,"given":"Nan-fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulalibieke","family":"Heizhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"issue":"2","key":"2745_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"L. Mosso, C. Carvajal, A. Gonz\u00e1lez, A. Barraza, F. Avila, J. Montero, A. Huete, A. Gederlini, C.E. Fardella, Primary aldosteronism and hypertensive disease. Hypertension 42(2), 161\u2013165 (2003). https:\/\/doi.org\/10.1161\/01.HYP.0000079505.25750.11","journal-title":"Hypertension"},{"issue":"14","key":"2745_CR2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo, L. Gabetti, G. Mengozzi, T.A. Williams, F. Rabbia, F. Veglio, P. Mulatero, Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J. Am. Coll. Cardiol. 69(14), 1811\u20131820 (2017). https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"2745_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052.","volume":"75","author":"Z Xu","year":"2020","unstructured":"Z. Xu, J. Yang, J. Hu, Y. Song, W. He, T. Luo, Q. Cheng, L. Ma, R. Luo, P.J. Fuller, J. Cai, Q. Li, S. Yang, Chongqing Primary Aldosteronism Study (CONPASS) Group. Primary Aldosteronism in Patients in China With Recently Detected Hypertension. J. Am. Coll. Cardiol. 75(16), 1913\u20131922 (2020). https:\/\/doi.org\/10.1016\/j.jacc.2020.02.052.","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"2745_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, M.J. Mattarello, A. Moretti, G. Palumbo, G. Parenti, E. Porteri, A. Semplicini, D. Rizzoni, E. Rossi, M. Boscaro, A.C. Pessina, F. Mantero, PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48(11), 2293\u20133000 (2006). https:\/\/doi.org\/10.1016\/j.jacc.2006.07.059","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"2745_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita, P. Mulatero, Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"2745_CR6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","volume":"38","author":"M Parasiliti-Caprino","year":"2020","unstructured":"M. Parasiliti-Caprino, C. Lopez, N. Prencipe, B. Lucatello, F. Settanni, G. Giraudo, D. Rossato, G. Mengozzi, E. Ghigo, A. Benso, M. Maccario, Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. J. Hypertens. 38(9), 1841\u20131848 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002441","journal-title":"J. Hypertens."},{"issue":"9","key":"2745_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11886-019-1185-x","volume":"21","author":"GL Hundemer","year":"2019","unstructured":"G.L. Hundemer, Primary Aldosteronism: cardiovascular Outcomes Pre- and Post-treatment. Curr. Cardiol. Rep. 21(9), 93 (2019). https:\/\/doi.org\/10.1007\/s11886-019-1185-x","journal-title":"Curr. Cardiol. Rep."},{"issue":"6","key":"2745_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"A. Vaidya, P. Mulatero, R. Baudrand, G.K. Adler, The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr. Rev. 39(6), 1057\u20131088 (2018). https:\/\/doi.org\/10.1210\/er.2018-00139","journal-title":"Endocr. Rev."},{"issue":"12","key":"2745_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0043-119755","volume":"49","author":"F Buffolo","year":"2017","unstructured":"F. Buffolo, S. Monticone, J. Burrello, M. Tetti, F. Veglio, T.A. Williams, P. Mulatero, Is Primary Aldosteronism Still Largely Unrecognized? Horm. Metab. Res. 49(12), 908\u2013914 (2017). https:\/\/doi.org\/10.1055\/s-0043-119755","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"2745_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","volume":"165","author":"BC Ruhle","year":"2019","unstructured":"B.C. Ruhle, M.G. White, S. Alsafran, E.L. Kaplan, P. Angelos, R.H. Grogan, Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives. Surgery 165(1), 221\u2013227 (2019). https:\/\/doi.org\/10.1016\/j.surg.2018.05.085","journal-title":"Surgery"},{"issue":"11","key":"2745_CR11","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"P. Mulatero, S. Monticone, J. Burrello, F. Veglio, T.A. Williams, J. Funder, Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J. Hypertens. 34(11), 2253\u20132257 (2016). https:\/\/doi.org\/10.1097\/HJH.0000000000001088","journal-title":"J. Hypertens."},{"issue":"1","key":"2745_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"J.M. Brown, M. Siddiqui, D.A. Calhoun, R.M. Carey, P.N. Hopkins, G.H. Williams, A. Vaidya, The Unrecognized Prevalence of Primary Aldosteronism: a Cross-sectional Study. Ann. Intern. Med. 173(1), 10\u201320 (2020). https:\/\/doi.org\/10.7326\/M20-0065. Epub 2020 May 26","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"2745_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr, The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016). https:\/\/doi.org\/10.1210\/jc.2015-4061","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"2745_CR14","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"S.C. K\u00e4yser, T. Dekkers, H.J. Groenewoud, G.J. van der Wilt, J. Carel Bakx, M.C. van der Wel, A.R. Hermus, J.W. Lenders, J. Deinum, Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: a Systematic Review and Meta-Regression Analysis. J. Clin. Endocrinol. Metab. 101(7), 2826\u20132835 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1472","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2745_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11154-011-9157-5.","volume":"12","author":"RJ Auchus","year":"2011","unstructured":"R.J. Auchus, Primary aldosteronism and a Texas two-step. Rev. Endocr. Metab. Disord. 12(1), 37\u201342 (2011). https:\/\/doi.org\/10.1007\/s11154-011-9157-5.","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"2745_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/HJH.0000000000001511","volume":"36","author":"T Yamashita","year":"2018","unstructured":"T. Yamashita, S. Shimizu, M. Koyama, K. Ohno, T. Mita, T. Tobisawa, A. Takada, N. Togashi, Y. Ohnuma, T. Hasegawa, A. Tsuchida, T. Endo, T. Ando, H. Yoshida, S. Fukuma, S. Fukuhara, N. Moniwa, T. Miura, Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K. J. Hypertens. 36(2), 326\u2013334 (2018). https:\/\/doi.org\/10.1097\/HJH.0000000000001511","journal-title":"J. Hypertens."},{"issue":"3","key":"2745_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/cen.14142","volume":"92","author":"N Kietsiriroje","year":"2020","unstructured":"N. Kietsiriroje, R. Wonghirundecha, O. Suntornlohanakul, R.D. Murray, Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism. Clin. Endocrinol. (Oxf.) 92(3), 196\u2013205 (2020). https:\/\/doi.org\/10.1111\/cen.14142","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"2745_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cen.12981","volume":"85","author":"Y Jiang","year":"2016","unstructured":"Y. Jiang, C. Zhang, L. Ye, T. Su, W. Zhou, L. Jiang, Y. Zhang, W. Wang, Factors affecting parathyroid hormone levels in different types of primary aldosteronism. Clin. Endocrinol. (Oxf.) 85(2), 267\u2013274 (2016). https:\/\/doi.org\/10.1111\/cen.12981","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"2745_CR19","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser, W.F. Young Jr, V.M. Montori, Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(9), 3266\u20133281 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0104","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2745_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","volume":"71","author":"Y Song","year":"2018","unstructured":"Y. Song, S. Yang, W. He, J. Hu, Q. Cheng, Y. Wang, T. Luo, L. Ma, Q. Zhen, S. Zhang, M. Mei, Z. Wang, H. Qing, D. Bruemmer, B. Peng, Q. Li, Chongqing Primary Aldosteronism Study (CONPASS) Group\u2020. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: a Prospective Diagnostic Accuracy Study. Hypertension 71(1), 118\u2013124 (2018). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10197","journal-title":"Hypertension"},{"issue":"1","key":"2745_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"G.P. Rossi, R.J. Auchus, M. Brown, J.W. Lenders, M. Naruse, P.F. Plouin, F. Satoh, W.F. Young Jr, An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63(1), 151\u2013160 (2014). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02097","journal-title":"Hypertension"},{"issue":"12","key":"2745_CR22","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/jcm8122194","volume":"8","author":"MK Kwak","year":"2019","unstructured":"M.K. Kwak, J.Y. Lee, B.J. Kim, S.H. Lee, J.M. Koh, Effects of Primary Aldosteronism and Different Therapeutic Modalities on Glucose Metabolism. J. Clin. Med. 8(12), 2194 (2019). https:\/\/doi.org\/10.3390\/jcm8122194","journal-title":"J. Clin. Med."},{"issue":"1","key":"2745_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cen.13891","volume":"90","author":"AMA Berends","year":"2019","unstructured":"A.M.A. Berends, E. Buitenwerf, E.G. Gruppen, W.J. Sluiter, S.J.L. Bakker, M.A. Connelly, M.N. Kerstens, R.P.F. Dullaart, Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. Clin. Endocrinol. (Oxf.) 90(1), 79\u201387 (2019). https:\/\/doi.org\/10.1111\/cen.13891","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"2745_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1507\/endocrine1927.68.1_51","volume":"68","author":"M Namba","year":"1992","unstructured":"M. Namba, K. Kikuchi, H. Komura, S. Suzuki, N. Satoh, T. Ohtomo, T. Takada, S. Marusaki, O. Iimura, Study on uric acid metabolism in patients with primary aldosteronism. Nihon Naibunpi Gakkai Zasshi 68(1), 51\u201361 (1992). https:\/\/doi.org\/10.1507\/endocrine1927.68.1_51","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"issue":"4","key":"2745_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.23736\/S0391-1977.18.02867-5","volume":"44","author":"HH Loh","year":"2019","unstructured":"H.H. Loh, A. Yee, H.S. Loh, Bone health among patients with primary aldosteronism: a systematic review and meta-analysis. Minerva Endocrinol. 44(4), 387\u2013396 (2019). https:\/\/doi.org\/10.23736\/S0391-1977.18.02867-5","journal-title":"Minerva Endocrinol."},{"issue":"4","key":"2745_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1620\/tjem.84.339","volume":"84","author":"R Shioji","year":"1965","unstructured":"R. Shioji, S. Abe, S. Rikimaru, Effects of Salt Restriction, Spironolactone, and Ammonium Chloride on Acid-base Relations in a Case of Primary Aldosteronism. Tohoku J. Exp. Med. 84(4), 339\u2013348 (1965). https:\/\/doi.org\/10.1620\/tjem.84.339","journal-title":"Tohoku J. Exp. Med."},{"issue":"23","key":"2745_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21037\/atm.2019.08.63","volume":"7","author":"ZR Zhou","year":"2019","unstructured":"Z.R. Zhou, W.W. Wang, Y. Li, K.R. Jin, X.Y. Wang, Z.W. Wang, Y.S. Chen, S.J. Wang, J. Hu, H.N. Zhang, P. Huang, G.Z. Zhao, X.X. Chen, B. Li, T.S. Zhang, In-depth mining of clinical data: the construction of clinical prediction model with R. Ann. Transl. Med. 7(23), 796 (2019). https:\/\/doi.org\/10.21037\/atm.2019.08.63","journal-title":"Ann. Transl. Med"},{"issue":"1","key":"2745_CR28","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","volume":"170","author":"KGM Moons","year":"2019","unstructured":"K.G.M. Moons, R.F. Wolff, R.D. Riley, P.F. Whiting, M. Westwood, G.S. Collins, J.B. Reitsma, J. Kleijnen, S. Mallett, PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration. Ann. Intern. Med. 170(1), W1\u2013W33 (2019). https:\/\/doi.org\/10.7326\/M18-1377","journal-title":"Ann. Intern. Med."},{"key":"2745_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000486060","volume":"50","author":"D Goltzman","year":"2018","unstructured":"D. Goltzman, M. Mannstadt, C. Marcocci, Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. Front. Horm. Res. 50, 1\u201313 (2018). https:\/\/doi.org\/10.1159\/000486060","journal-title":"Front. Horm. Res."},{"issue":"3","key":"2745_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/qjmed\/hcw224.","volume":"110","author":"TH Toh","year":"2017","unstructured":"T.H. Toh, C.V. Tong, H.C. Chong, Primary aldosteronism-not just about potassium and blood pressure. QJM 110(3), 175\u2013177 (2017). https:\/\/doi.org\/10.1093\/qjmed\/hcw224.","journal-title":"QJM"},{"issue":"5","key":"2745_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-17-0417","volume":"177","author":"AS Salcuni","year":"2017","unstructured":"A.S. Salcuni, V. Carnevale, C. Battista, S. Palmieri, C. Eller-Vainicher, V. Guarnieri, F. Pugliese, G. Guglielmi, G. Desina, S. Minisola, I. Chiodini, A. Scillitani, Primary aldosteronism as a cause of secondary osteoporosis. Eur. J. Endocrinol. 177(5), 431\u2013437 (2017). https:\/\/doi.org\/10.1530\/EJE-17-0417","journal-title":"Eur. J. Endocrinol."},{"key":"2745_CR32","doi-asserted-by":"publisher","first-page":"836529","DOI":"10.1155\/2014\/836529","volume":"2014","author":"L Petramala","year":"2014","unstructured":"L. Petramala, L. Zinnamosca, A. Settevendemmie, C. Marinelli, M. Nardi, A. Concistr\u00e8, F. Corpaci, G. Tonnarini, G. De Toma, C. Letizia, Bone and mineral metabolism in patients with primary aldosteronism. Int J. Endocrinol. 2014, 836529 (2014). https:\/\/doi.org\/10.1155\/2014\/836529","journal-title":"Int J. Endocrinol."},{"issue":"2","key":"2745_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451.","volume":"30","author":"C Maniero","year":"2012","unstructured":"C. Maniero, A. Fassina, T.M. Seccia, A. Toniato, M. Iacobone, M. Plebani, R. De Caro, L.A. Cal\u00f2, A.C. Pessina, G.P. Rossi, Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J. Hypertens. 30(2), 390\u2013395 (2012). https:\/\/doi.org\/10.1097\/HJH.0b013e32834f0451.","journal-title":"J. Hypertens."},{"issue":"1","key":"2745_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-018-2231-z","volume":"471","author":"G Jacquillet","year":"2019","unstructured":"G. Jacquillet, R.J. Unwin, Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflug. Arch. 471(1), 83\u201398 (2019). https:\/\/doi.org\/10.1007\/s00424-018-2231-z","journal-title":"Pflug. Arch."},{"issue":"2","key":"2745_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","volume":"470","author":"B Zhang","year":"2016","unstructured":"B. Zhang, A.T. Umbach, H. Chen, J. Yan, H. Fakhri, A. Fajol, M.S. Salker, D. Spichtig, A. Daryadel, C.A. Wagner, M. F\u00f6ller, F. Lang, Up-regulation of FGF23 release by aldosterone. Biochem. Biophys. Res. Commun. 470(2), 384\u2013390 (2016). https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.034","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"2745_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/10641963.2012.712175","volume":"35","author":"N Li","year":"2013","unstructured":"N. Li, M. Wang, H. Wang, D. Zhang, X. Wang, F. Zu, G. Chang, K. Zhou, Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia. Clin. Exp. Hypertens. 35(3), 175\u2013182 (2013). https:\/\/doi.org\/10.3109\/10641963.2012.712175","journal-title":"Clin. Exp. Hypertens."},{"issue":"3","key":"2745_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cen.13370","volume":"87","author":"M Tancredi","year":"2017","unstructured":"M. Tancredi, G. Johannsson, B. Eliasson, R. Eggertsen, U. Lindblad, S. Dahlqvist, H. Imberg, M. Lind, Prevalence of primary aldosteronism among patients with type 2 diabetes. Clin. Endocrinol. (Oxf.) 87(3), 233\u2013241 (2017). https:\/\/doi.org\/10.1111\/cen.13370","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"2745_CR38","doi-asserted-by":"publisher","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","volume":"105","author":"Y Hu","year":"2020","unstructured":"Y. Hu, J. Zhang, W. Liu, X. Su, Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension. J. Clin. Endocrinol. Metab. 105(4), dgz293 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz293","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2745_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","volume":"183","author":"W Chen","year":"2014","unstructured":"W. Chen, F. Li, C. He, Y. Zhu, W. Tan, Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir. J. Med. Sci. 183(2), 283\u2013291 (2014). https:\/\/doi.org\/10.1007\/s11845-013-1007-x","journal-title":"Ir. J. Med. Sci."},{"issue":"10","key":"2745_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/jcm7100360","volume":"7","author":"CH Chang","year":"2018","unstructured":"C.H. Chang, Y.H. Hu, K.H. Huang, Y.H. Lin, Y.C. Tsai, C.H. Wu, S.Y. Yang, C.C. Chang, C.C. Lu, K.D. Wu, V.C. Wu, Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus. J. Clin. Med. 7(10), 360 (2018). https:\/\/doi.org\/10.3390\/jcm7100360","journal-title":"J. Clin. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02745-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T09:22:21Z","timestamp":1627723341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02745-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2745"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02745-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}